-
-
-
-
-
-
-
UPDATE: Barclays Starts Solid Biosciences (SLDB) at Overweight
-
-
-
-
-
-
-
UPDATE: Barclays Upgrades Halozyme Therapeutics (HALO) to Equalweight
-
-
-
-
-
-
-
Barclays Downgrades Nightstar Therapeutics (NITE) to Equalweight Following Acquisition
-
-
-
-
-
-
-
Barclays Starts LogicBio Therapeutics (LOGC) at Overweight
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Defended at Barclays
-
-
-
-
-
-
-
UPDATE: Barclays Upgrades PTC Therapeutics (PTCT) to Equalweight
-
-
-
-
-
-
-
Barclays Downgrades PTC Therapeutics (PTCT) to Underweight
-
119 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All